The AMR Policy Accelerator addresses AMR policy research gaps and supports effective global and national policymaking with the ultimate aim of sustainable antimicrobial use for everyone. We incorporate a One Health approach by bringing together academics, civil society actors and policymakers from all sectors for a diverse set of perspectives on AMR. We are committed to integrating equity considerations in our advisory services.
Our Advisory Services leverage Global Strategy Lab’s proven track record for developing scientific evidence to inform public policy and AMR governance. Combining the expertise of a university-affiliated research lab with a context-responsive policy consultancy allows us to provide fully customizable advisory offerings that are unique in the AMR policy world.
Our flexible, tailored approach supports policymakers navigating different stages in their own policy processes. Our Advisory Services are offered at a competitive price point with subsidized services available for low- and middle- income countries (LMICs).
Advisory offerings are built specific to policymakers’ timelines, available resources, and needs and can be scaled to provide solutions within 3-, 10-, 30-, 60-, and 90-day windows. Early-stage interventions include evidence synthesis, contextualized policy options, and SGBA+ and ethics reviews. Our later-stage interventions include our implementation and evaluation offerings.
Types of advisory support offered
Implementation & Evaluation
Ethics & Sex-and-gender-based analysis+
Convening Policy Dialogues
To discuss any of our services or other unique solutions to your policy needs:
A Framework for Gender Analysis in One Health AMR Policy
While gender can impact access to antimicrobials and influence exposure to pathogens, few national action plans (NAPs) on AMR include gender-specific or gender-related activities and most fail to consider gender as a driver of inequity in AMR-related outcomes. This research will improve our understanding of the intersections of gender and AMR from a One Health perspective and provide recommendations for gender-mainstreaming in AMR NAPs.
Expected Dissemination: Q4, 2023
Addressing AMR to Accelerate Progress on the United Nations SDGs
Antimicrobial resistance (AMR) is a global health and development threat with far-reaching consequences. If not urgently addressed, AMR will impede progress on the United Nations (UN) Sustainable Development Goals (SDGs), particularly in areas of global health, food safety and security, economic growth, poverty alleviation, and the environment This research will identify policy intervention opportunities that create joint accelerated progress on AMR goals and the SDGs.
Expected Dissemination: Q1, 2024
National Governance Models for One Health Collaboration on AMR
Effectively responding to AMR at the national level requires countries to coordinate across the human, animal, environment, and agricultural sectors to implement their national action plans. Currently, there is little practical guidance available on how to structure national multi-sectoral AMR coordination committees. This research looks at the evidence to identify key institutional design considerations for structuring multisectoral AMR committees and achieving effective coordination.
Expected Dissemination: Q1, 2024
Policy Pathways for Responsible Use of Antimicrobials in Animal Production
Globally, two thirds of all antimicrobials used are consumed by livestock production systems. This widespread use of antimicrobials in livestock has implications for the environment, food safety and the economy. Policies targeting indiscriminate use of antimicrobials are essential to maintaining the effectiveness of antimicrobials and preserving the security of our food systems. This research will map potential policy pathways and interventions to promote the prudent and responsible use of antimicrobials in animal production systems, with a focus on low- and middle- income countries (LMICs).
Feedback on this project can be sent to Dr. Fiona Emdin.
Expected Dissemination: Q2, 2024